We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Hemodialysis Catheter Maintains Long-Term Patency

By HospiMedica International staff writers
Posted on 27 Apr 2021
An innovative hemodialysis catheter with a unique lumen design can maintain primary patency rates for up to 180 days. More...


The BD (Franklin Lakes, NJ, USA) Pristine Long-Term 15.5F hemodialysis catheter boasts a side-hole free symmetric Y-Tip distal lumen, which is aimed to minimize thrombus adhesion (a problem commonly associated with side-hole catheters), facilitate blood clot aspiration prior to hemodialysis, and minimize recirculation rates in both forward and reverse flows. In a prospective feasibility study, which followed 45 patients who received the Pristine Catheter for six months, all catheters were patent at 60-days, and 90.9% remained patent at 180-days post procedure.

“The BD Pristine Catheter adds to our diversified portfolio of products in support of clinicians who care for patients with end stage kidney disease (ESKD) who require hemodialysis,” said Padraic O'Brien, worldwide president of peripheral intervention at BD. “This exciting technology is highly complementary to our current ESKD portfolio, and will enable us to offer a differentiated product that can help to improve the patient experience.”

“A majority of hemodialysis patients in the United States start their treatment with a catheter, and many of those catheter-dependent patients will suffer a catheter-related complication at some point during treatment, which can adversely impact the patient and create additional healthcare system costs,” said Michael Tal, MD, founder of Pristine Access Technologies (Israel), and inventor of the Pristine Catheter. “The Pristine Catheter was designed with hemodialysis patients in mind and to help address some of these concerns.”

While an arteriovenous fistula (AVF) remains the preferred access option for patients on hemodialysis therapy, these often can take four months or longer to mature, and a catheter is often required during this time period; but more than 40% of such patients develop a venous obstruction. Many patients, in fact, prefer a catheter over an AVF, for reasons that include inadequate preparation for dialysis, phobia or avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
BD


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.